Résultats de la recherche - Li, Yi-Heng
- Résultat(s) 1 - 20 résultats de 54
- Aller à la page suivante
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Cilostazol Improves Proangiogenesis Functions in Human Early Endothelial Progenitor Cells through the Stromal Cell-Derived Factor System and Hybrid Therapy Provides a Synergistic E... par Tseng, Shih-Ya, Chao, Ting-Hsing, Li, Yi-Heng, Cho, Chung-Lung
Publié 2016Texte -
10
Management of acute coronary syndrome in patients with suspected or confirmed coronavirus disease 2019: Consensus from Taiwan Society of Cardiology par Li, Yi-Heng, Wang, Mei-Tzu, Huang, Wei-Chun, Hwang, Juey-Jen
Publié 2021Texte -
11
-
12
Appropriate Use of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors for Atherosclerotic Cardiovascular Disease: Comparison of Recommendations from Different Guideli... par Lin, Jia-Ling, Huang, Po-Hsun, Yeh, Hung-I, Li, Yi-Heng
Publié 2020Texte -
13
Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Elevated in Patients With Peripheral Artery Disease and Associated With Metabolic Disorders and Dysfunction in Ci... par Chao, Ting‐Hsing, Chen, I‐Chih, Li, Yi‐Heng, Lee, Po‐Tseng, Tseng, Shih‐Ya
Publié 2016Texte -
14
-
15
-
16
Lipid Lowering Therapy for Acute Coronary Syndrome and Coronary Artery Disease: Highlights of the 2017 Taiwan Lipid Guidelines for High Risk Patients par Li, Yi-Heng, Chao, Ting-Hsing, Liu, Ping-Yen, Ueng, Kwo-Chang, Yeh, Hung-I
Publié 2018Texte -
17
-
18
-
19
Elevation of the soluble thrombomodulin levels is associated with inflammation after percutaneous coronary interventions par Chao, Ting‐Hsing, Li, Yi‐Heng, Tsai, Wei‐Chuan, Chen, Jyh‐Hong, Liu, Ping‐Yen, Tsai, Liang‐Miin
Publié 2006Texte -
20